However, their accuracy is limited, US has an overall sensitivity of 84% in clinical screening and diagnosis of HCC patients, but its sensitivity is affected by the tumor diameter (3); the sensitivity of serum AFP in the diagnosis of early HCC ranges from 45.3% to 62.0%, with a specificity of 87% to 93% (4). Here, AFP is linked to hepatocellular carcinoma.